EVALUATION OF THE GASTROPROTECTIVE EFFECT OF MISOPROSTOL, CHITOSAN AND THEIR COMBINATION ON INDOMETHACIN INDUCED GASTRIC ULCER IN RATS.

Background: The study was designed to evaluate the anti-ulcer effect of chitosan, misoprostol, and their combination on gastric ulceration induced by indometacin in rats. Methods and experimental design: Chitosan was prepared from shrimp shells waste products. Thirty rats were divided into 5 groups, 6 rats each. Rats in group 1 (control) were given solid sugar and distilled water for 3 days; group 2 were treated by indometacin (25mg/rat) ; group 3,4, and 5 were treated by misoprostol, chitosan, and by the combination chitosan and misoprostol respectively before treatment with indometacin. Blood were collected before sacrificing the animals and used for estimation of MDA, a marker of oxidative stress. The stomachs were prepared for estimating the total gastric area, ulcerated area, tissue MDA, mucin production as well as for histopathological examination. Results: Indometacin produced gastric ulcers, and increased the total gastric area in all animals. These effects were associated with a significant elevation of MDA levels in the blood and in stomach tissues, and a significant reduction in mucin production. Misoprostol, chitosan and their combination protected gastric mucosa since they significantly reduced ulcer index. Moreover, the observed anti-ulcer effect was more with the combination in comparison to monotherapy of misoprostol or chitosan. Treatments by misoprostol, chitosan and their combination before indometacin significantly reduced blood and tissue MDA levels and increased mucin production. Conclusion: Chitosan, misoprostol and their combination have gastroprotective effects against indometacin-induced gastric ulceration in rats. INTRODUCTION ong term use of NSAIDs causes gastric or duodenal ulceration in some patients with serious complications such as hemorrhage or even gastrointestinal perforation. [1] With the development of advanced endoscopy techniques such as capsule endoscopy and balloon enteroscopy, NSAIDs were found to cause damage to the small intestine in about 50% of patients receiving these drugs. [2] The pathophysiology of NSAIDsinduced gastric ulceration can be considered as instability among the injurious factors, direct gastric tissue injury by the drug, gastric acid, pepsin, infection by Helicobactor pylori and the protective factors, bicarbonate secretion, mucus and prostaglandins. The current approach of treatment is directed to the reduction of injurious factors and to strengthen mucosa protection of the stomach and duodenum through cytoprotective agents. [3] Indometacin, one of the NSAIDs groups labeled as powerful prostaglandin inhibitors, [1] is frequently associated with gastrointestinal ulceration and bleeding. The aim of this study is to investigate the gastro-protective effect of chitosan, a polymer with gastro-protective effect, [5] misoprostol, a prostaglandin analogue [4] or their combination in indometacin induced gastric ulceration in rats. MATERIALS AND METHODS Animals handling Thirty males and females albino rats were purchased from the College of Science, L MJBU, Vol 29, No. 1&2, 2011 2 University of Basrah. They were three month old, 200g average weight, and were considered healthy by general examination. The animals were divided into 5 groups, six animals each Preparation of drugs Drugs were administered by oral gavage using modified insulin syringes. Since the body weights of animals ranged from (197-205 g), fixed doses of the indometacin were given [6] as follow: indometacin 25mg/rat, by suspending one capsule of indometacin (Indylon 25mg, Medochemie, Cyprus), in 1 ml distilled water, and misoprostol tablet (Cytotec 200 μg, Searle, UK), suspended in 10ml distilled water, and administered in a dose of 20 μg /rat. Chitosan was prepared locally from shrimp shell wastes according to the method of Weska et al. [7] This yielded high molecular weight (HMW) chitosan, then low molecular weight (LMW) chitosan was obtained according to the method of Yong et al. [8] Chitosan was tested by infrared spectrophotometry. Calculation of molecular weight was performed to satisfy standard specifications. LMW chitosan was then suspended in 1ml distilled water and given in a dose of 400 mg/rat. Experimental design The study protocol was described as follow: Group Day 0 –Day 7 Day8 Day 9Day 12 Group 1 Control Normal diet Fasting Distilled water Group2 Indometacin (I) treatment Normal diet Fasting Indometacin daily (25mg / rat) Group 3 Misoprostol (M) treatment Normal diet + (M) (20μg/day) Fasting Indometacin daily (25mg / rat) Group 4 Chitosan (C) treatment Normal diet +( C)(400mg/day) Fasting Indometacin daily (25mg / rat) Group 5 Combination (M+C) Normal diet + (M+C) Fasting Indometacin daily (25mg / rat) All treatments were administered orally. At the end of each study protocol and before sacrificing the animals blood samples were collected directly from the heart, the animals were then sacrificed under light chloroform anesthesia. Preparation of the stomach A longitudinal incision from abdomen toward chest cavity was made. The stomach was dissected from the other viscera and separated by means of two incisions, the first one at the cardiac sphincter and the other at the pyloric sphincter. [9] The stomach was then opened along the greater curvature, total gastric area (T.G.A); gastric lesions as ulcer index (U.I.) were measured by digital caliper. Parts of gastric mucosa were removed for measurement of MDA and free mucin levels. Finally the stomach was immersed in 7y10% formalin solution for histopathological examination. The percentages of inhibition of ulcer index in relation to the indometacin treatment were calculated according to Dengizet al., [10] formula, Inhibition percentage = U.I. treatment/U.I. (indometacin) × 100 The collected blood or stomach tissue samples were analyzed as follow: Measurements of serum MDA level by thiobarbituric acid assay described by Beuge and Aust. [11] Measurements of stomach tissue MJBU, Vol 29, No. 1&2, 2011 3 MDA according to the method of Cassini et al. [12] Measurements of free mucin in stomach tissue by measuring the amount of Alcian blue dye. [13] Statistical analysis One way analysis of variance (ANOVA) was carried out by SPSS computer package version 11. The differences were considered significant at P < 0.05. RESULTS Effect of treatments on total gastric area The mean total gastric area of the control was (875.1±33.5 mm 2 ) which was slightly increased to (1003.3±11.9 mm 2 ) in the group which received indometacin. This difference was statistically significant (P<0.05). The mean total gastric area in the rats which received misoprostol, LMW chitosan and the combination of LMW chitosan and misoprostol were (888.5 ± 113.5 mm 2 , 893.8 ± 44.6 mm 2 and 881.1 ± 53mm 2 ) respectively. These values are not significantly different from the control group value (871.1 ± 33.5 mm 2 ) (table-1). Effects of treatments on ulcer index There were no ulcers found in the rats treated with distilled water (control group). In the rats treated by indometacin (25mg/rat) there were gastric ulcers seen, and the mean calculated ulcer index was (151.8 ± 27.1mm 2 ). Treatment by misoprostol (20 μg/rat) daily for 7 days administered before indometacin (25mg/rat) daily for 3 days significantly reduced the mean ulcer index to (28 ± 6.7mm 2 ) in comparison to the mean ulcer index value of indometacin, (P<0.05). In the LMW chitosan treated rats, four animals had no ulcer and in two small areas of ulceration were seen. The mean ulcer index in LMW chitosan treated rats was (3.6 ± 5.7mm 2 ) which was significantly lower than that of misoprostol (P<0.05) and indometacin (P<0.05). There was no ulcer, necrosis or hyperemia seen in all animals (n=6) which were treated by the combination of LMW chitosan plus misoprostol (LMW chitosan 400 mg/rat + Misoprostol 20 μg / rat daily for 7 days) (table-1). Effects of treatments on blood MDA The mean MDA level of the control was (0.92 ± 0.15 μmol/L). In indometacin treated group the mean MDA level significantly increased to (2.28 ± 0.22 μmol/L) (P<0.05). Misoprostol prior to indometacin treatment has resulted in a mean MDA level of (2.01 ± 0.07 μmol/L) which was slightly but significantly lower than that of indometacin (P<0.05), but, still was higher than the MDA level of the control treated group. When LMW chitosan was administered prior to indometacin, the mean blood MDA became (1.48 ± 0.93 μmol/L) which was significantly lower than that of indometacin (P<0.05). The mean MDA level measured for LMW chitosan plus misoprostol administration prior to indometacin was (0.98 ± 0.18 μmol/L) which was reduced towards the value of the control group (0.92 ± 0.15 μmol/L) (table-1). Effects of treatments on tissue MDA Stomach tissue MDA was measured for the control group and was (2.1±0.91 ηmol /mg). In indometacin treated group the mean value of tissue MDA significantly increased to (15.7 ± 2.58 ηmol/mg) (P<0.05). Misoprostol prior to indometacin treatment has resulted in a tissue MDA level of (2.7 ± 1.42 ηmol/mg) which was significantly lower than that of indometacin, but, was slightly higher than that of the control group. The value of tissue MDA of the two groups, which were treated by LMW chitosan alone and chitosan plus misoprostol prior to indometacin was found to be (0.8 ± 0.98 ηmol/mg) and (0.7 ± 0.05 ηmol/mg) for to the two treatments respectively. These values were significantly lower than the level of the tissue MDA of the control group (P<0.05) (table-1). Effects of treatments on mucin secretion The mean value of mucin in the control group was (0.134 ± 0.002 ml/cm 2 ). There was a great and statistically significant reduction of mucin MJBU, Vol 29, No. 1&2, 2011